BiotechTube
Home/AAVogen/Chris Novashinski
CN

Chris Novashinski

Regulatory Affairs Director, Co-Founder & COO (RareMoon)

AAVogen

Therapeutic Areas

Muscle Wasting DiseasesNeuromuscular DiseasesCardiovascular Disease

AAVogen Pipeline

DrugIndicationPhase
AVGN7Inclusion Body Myositis (IBM)Pre-clinical
AVGN7 + AVGNDDuchenne Muscular Dystrophy (DMD)Pre-clinical

Leadership Team at AAVogen

B"
Buel "Dan" Rodgers, PhD
Founder & CEO
AM
Alexandra McPherron, PhD
Chief Scientific Officer (CSO)
JB
Jade Brown, MBA
Business Development Director
JR
Joseph Rininger, PhD
CMC Director
GC
Gary Carswell, CPA
CFO (contracted)
View full AAVogen profile